• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于热力学的经验法则来评估金属络合剂与血清和血浆中动力学不稳定金属离子的相互作用。

Thermodynamics-based rules of thumb to evaluate the interaction of chelators and kinetically-labile metal ions in blood serum and plasma.

机构信息

Institut de Chimie, UMR 7177, Université de Strasbourg, CNRS, 4 Rue Blaise Pascal, 67000, Strasbourg, France.

Institut Universitaire de France (IUF), 1 rue Descartes, 75231 Paris, France.

出版信息

Dalton Trans. 2023 Feb 21;52(8):2197-2208. doi: 10.1039/d2dt03875g.

DOI:10.1039/d2dt03875g
PMID:36734607
Abstract

Metal ions play a very important role in nature and their homeostasis is crucial. A lot of metal-related chemical research activities are ongoing that concern metal-based drugs or tools, such as chelation therapy, metal- and metabolite sensors, metallo-drugs and prodrugs, PET and MRI imaging agents, . In most of these cases, the applied chelator/ligand (L) or metal-ligand complex (M-L) has at least to pass the blood plasma to reach the target. Hence it is exposed to several metal-binding proteins (mainly serum albumin and transferrin) and to all essential metal ions (zinc, copper, iron, .). This holds also for studies in cultured cells when fetal calf serum is used in the medium. There is a risk that the applied compound (L or M-L) in the serum is transformed into a different entity, due to trans-metallation and/or ligand exchange reactions. This depends on the thermodynamics and kinetics. For kinetically-labile complexes, the complex stability with all the ligands and all metal ions present in serum is decisive in evaluating the thermodynamic driving force towards a certain fate of the chelator or metal-ligand complex. To consider that, an integrative view is needed on the stability constants, by taking into account all the metal ions present and all the main proteins to which they are bound, as well as the non-occupied metal binding site in proteins. Only then, a realistic estimation of the complex stability, and hence its potential fate, can be done. This perspective aims to provide a simple approach to estimate the thermodynamic stability of labile metal-ligand complexes in a blood plasma/serum environment. It gives a guideline to obtain an estimation of the plasma and serum complex stability and metal selectivity starting from the chemical stability constants of metal-ligand complexes. Although of high importance, it does not focus on the more complex kinetic aspects of metal-transfer reactions. The perspective should help for a better design of such compounds, to perform test tube assays which are relevant to the conditions in the plasma/serum and to be aware of the importance of ternary complexes, kinetics and competition experiments.

摘要

金属离子在自然界中起着非常重要的作用,它们的体内平衡至关重要。目前正在进行大量与金属相关的化学研究活动,涉及基于金属的药物或工具,如螯合疗法、金属和代谢物传感器、金属药物和前药、正电子发射断层扫描(PET)和磁共振成像(MRI)造影剂等。在大多数情况下,应用的螯合剂/配体(L)或金属-配体络合物(M-L)至少要通过血浆才能到达靶标。因此,它会暴露于几种金属结合蛋白(主要是血清白蛋白和转铁蛋白)和所有必需的金属离子(锌、铜、铁等)。当在培养基中使用胎牛血清时,这也适用于培养细胞的研究。由于转金属化和/或配体交换反应,应用于血清中的化合物(L 或 M-L)有可能转化为不同的实体,这存在风险。这取决于热力学和动力学。对于动力学不稳定的配合物,与血清中存在的所有配体和所有金属离子的配合物稳定性对于评估配体或金属-配体配合物向特定命运的热力学驱动力是决定性的。为了考虑这一点,需要考虑稳定性常数的综合观点,同时考虑到存在的所有金属离子和它们结合的所有主要蛋白质,以及蛋白质中未占据的金属结合位点。只有这样,才能对配合物的稳定性进行真实的估计,从而对其潜在命运进行估计。本文旨在提供一种简单的方法来估计在血浆/血清环境中不稳定的金属-配体配合物的热力学稳定性。它提供了一种从金属-配体配合物的化学稳定性常数出发,获得对血浆和血清配合物稳定性和金属选择性的估计的指南。虽然这一点非常重要,但它并不关注金属转移反应更复杂的动力学方面。该方法有助于更好地设计此类化合物,进行与血浆/血清条件相关的试管试验,并认识到三元配合物、动力学和竞争实验的重要性。

相似文献

1
Thermodynamics-based rules of thumb to evaluate the interaction of chelators and kinetically-labile metal ions in blood serum and plasma.基于热力学的经验法则来评估金属络合剂与血清和血浆中动力学不稳定金属离子的相互作用。
Dalton Trans. 2023 Feb 21;52(8):2197-2208. doi: 10.1039/d2dt03875g.
2
Solution Thermodynamics and Kinetics of Metal Complexation with a Hydroxypyridinone Chelator Designed for Thorium-227 Targeted Alpha Therapy.羟基吡啶酮配体与 227Th 靶向 α 治疗药物金属络合物的溶液热力学和动力学。
Inorg Chem. 2018 Nov 19;57(22):14337-14346. doi: 10.1021/acs.inorgchem.8b02430. Epub 2018 Oct 29.
3
NOTA Complexes with Copper(II) and Divalent Metal Ions: Kinetic and Thermodynamic Studies.具有铜(II)和二价金属离子的 NOTA 配合物:动力学和热力学研究。
Inorg Chem. 2018 Mar 19;57(6):3061-3072. doi: 10.1021/acs.inorgchem.7b02929. Epub 2018 Feb 28.
4
Advances on Chelation and Chelator Metal Complexes in Medicine.螯合作用与医学中螯合剂金属配合物的研究进展。
Int J Mol Sci. 2020 Apr 3;21(7):2499. doi: 10.3390/ijms21072499.
5
Chelation therapy for metal intoxication: comments from a thermodynamic viewpoint.金属中毒的螯合疗法:从热力学角度的评论。
Mini Rev Med Chem. 2013 Oct;13(11):1541-9. doi: 10.2174/13895575113139990077.
6
Integrating Prior Chemical Knowledge into the Graph Transformer Network to Predict the Stability Constants of Chelating Agents and Metal Ions.将先验化学知识融入图变换网络,以预测螯合剂和金属离子的稳定常数。
J Chem Inf Model. 2024 Aug 12;64(15):5867-5877. doi: 10.1021/acs.jcim.4c00614. Epub 2024 Jul 29.
7
Metal Chelation Therapy and Parkinson's Disease: A Critical Review on the Thermodynamics of Complex Formation between Relevant Metal Ions and Promising or Established Drugs.金属螯合疗法与帕金森病:相关金属离子与有前途或已确立药物之间形成配合物的热力学的批判性综述。
Biomolecules. 2019 Jul 9;9(7):269. doi: 10.3390/biom9070269.
8
Towards a model of non-equilibrium binding of metal ions in biological systems.构建生物系统中金属离子非平衡结合模型。
J Inorg Biochem. 2009 Feb;103(2):205-9. doi: 10.1016/j.jinorgbio.2008.10.003. Epub 2008 Oct 15.
9
Complexation of metal ions with TRAP (1,4,7-triazacyclononane phosphinic acid) ligands and 1,4,7-triazacyclononane-1,4,7-triacetic acid: phosphinate-containing ligands as unique chelators for trivalent gallium.金属离子与 TRAP(1,4,7-三氮杂环壬烷膦酸)配体和 1,4,7-三氮杂环壬烷-1,4,7-三乙酸的配合物:含膦酸酯的配体作为三价镓的独特螯合剂。
Inorg Chem. 2012 Jan 2;51(1):577-90. doi: 10.1021/ic202103v. Epub 2011 Dec 20.
10
Thermodynamic remarks on chelating ligands for aluminium related diseases.关于与铝相关疾病的螯合剂的热力学述评。
J Inorg Biochem. 2011 Nov;105(11):1518-22. doi: 10.1016/j.jinorgbio.2011.07.004. Epub 2011 Jul 31.

引用本文的文献

1
Decadentate Acyclic Chelators for Lanthanum Radiopharmaceuticals.用于镧放射性药物的十齿无环螯合剂。
J Med Chem. 2025 Aug 28;68(16):17823-17839. doi: 10.1021/acs.jmedchem.5c01558. Epub 2025 Aug 19.
2
Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of aβ by Metal Ion Stripping and Redox Silencing.Semax,一种铜螯合肽,通过金属离子剥离和氧化还原沉默作用降低Cu(II)催化的活性氧生成以及aβ的细胞毒性。
Bioinorg Chem Appl. 2025 Jun 3;2025:4226220. doi: 10.1155/bca/4226220. eCollection 2025.
3
Radiotheranostic landscape: A review of clinical and preclinical development.
放射诊疗全景:临床与临床前发展综述
Eur J Nucl Med Mol Imaging. 2025 Feb 1. doi: 10.1007/s00259-025-07103-7.
4
Elution behavior of drugs in high-speed counter-current chromatography using on-column complexation with metal ions.高速逆流色谱中药物与金属离子在线络合的洗脱行为。
Anal Sci. 2024 Jun;40(6):1121-1128. doi: 10.1007/s44211-024-00536-4. Epub 2024 Apr 9.